CGRP May Offer Both Migraine Treatment and Prevention ...Middle East

Medscape - News
Oral rimegepant, the first calcitonin gene-related peptide (CGRP) receptor antagonist approved for the acute treatment of migraine, was superior to placebo in preventing migraine in a phase 2/3 trial. Medscape Medical News

Hence then, the article about cgrp may offer both migraine treatment and prevention was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CGRP May Offer Both Migraine Treatment and Prevention )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News